The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $10.22

Today's change-0.22 -2.11%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $10.22

Today's change-0.22 -2.11%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.

Ironwood Pharmaceuticals Inc down (U.S.)$0.22

Ironwood Pharmaceuticals Inc closed sharply lower Wednesday, dropping (U.S.)$0.22 or 2.11% to (U.S.)$10.22. Over the last five days, shares have lost 2.57% and are down 11.82% for the last year to date. This security has underperformed the S&P 500 by 23.37% during the last year.

Key company metrics

  • Open(U.S.) $10.38
  • Previous close(U.S.) $10.44
  • High(U.S.) $10.68
  • Low(U.S.) $10.13
  • Bid / Ask(U.S.) $7.19 / (U.S.) $11.46
  • YTD % change-11.82%
  • Volume2,228,101
  • Average volume (10-day)2,490,751
  • Average volume (1-month)1,715,655
  • Average volume (3-month)1,554,703
  • 52-week range(U.S.) $7.35 to (U.S.) $14.50
  • Beta1.59
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.00
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue53402829
Total other revenue--------
Total revenue53402829
Gross profit53402029
Total cost of revenue0080
Total operating expense59667057
Selling / general / administrative32303330
Research & development28262927
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)09----
Other operating expenses, total--------
Operating income-6-26-42-28
Interest income (expense), net non-operating-10-10-6-5
Gain (loss) on sale of assets--------
Other--------
Income before tax-14-47-48-33
Income after tax-14-47-48-33
Income tax, total--------
Net income-14-47-48-33
Total adjustments to net income--------
Net income before extra. items-14-47-48-33
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-14-47-48-33
Inc. avail. to common incl. extra. items-14-47-48-33
Diluted net income-14-47-48-33
Dilution adjustment--0----
Diluted weighted average shares143142142141
Diluted EPS excluding extraordinary itemsvalue per share-0.10-0.33-0.34-0.24
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.10-0.27-0.34-0.24